The Trump administration has expanded access to nicotine products despite concerns from public health critics about youth use and addiction.

The Food and Drug Administration on Tuesday cleared Philip Morris-owned Zyn nicotine pouches to be marketed as less harmful than cigarettes, giving the tobacco giant a major regulatory win as the Trump administration loosens restrictions on nicotine products.

The decision, first reported by Axios, allows 20 Zyn products to carry a modified-risk claim saying that switching from cigarettes to Zyn lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.

Zyn pouches contain nicotine but not tobacco. They are placed between a user’s gum and lip and have surged in popularity among conservatives, tech workers and others who promote them as a cleaner alternative to cigarettes and chewing tobacco or a productivity aid.

  • phdepressed@sh.itjust.works
    0·
    3 days ago

    If it were the burning then dip/chew wouldn’t be a cause for mouth and throat cancer. The 1.5-6 mgs in a zyn vs the 1mg/100kg of tomato is a very different dosage. Nicotine alone can be cytotoxic and promote EMT both factors that can indicate cancer risk.

    Flavoring problems arent really a reach considering some have induced severe and deadly responses in people who vape.

    • CmdrShepard49@sh.itjust.works
      0·
      3 days ago

      Dip/chew is also made from the same tobacco as cigarettes. Zyns aren’t made with tobacco.

      Also the rate of oral cancer from smokeless tobacco is already significantly lower than than it is for smokers.

      The oral cancer incidence rate among adults who smoke was significantly higher than the ST group (2.6 times higher, 95% CI 2.0‐3.3, P<.001), 3.6 (95% CI 3.2‐4.1, P<.001) times higher than the never users, and 2.4 (95% CI 1.8‐3.1, P<.001) times higher compared to former smokers who now use ST.

      https://cancer.jmir.org/2024/1/e51936/